Find a Trial

Trial Summary

Protocol No.J13104
Principal InvestigatorZellars, Richard
PhasePhase II
Age GroupAdult
TitleA Randomized Phase II Study of Partial Breast Irradiation and Sequential vs. Concurrent Chemotherapy in Women with Early Stage Breast Cancer (PBI 3.0)
DescriptionWomen with ER negative breast cancer have a higher risk of the cancer returning in the breast after whole or partial breast radiation than women with ER positive breast cancer. In a small study at Johns Hopkins, women were treated with partial breast irradiation and chemotherapy given at the same time. This combined treatment was safe and women with ER negative breast cancer did just as well as women with ER positive cancer. We are now testing in a bigger study whether giving partial breast irradiation and chemotherapy at the same time (our new method) has the same side effects and outcomes as giving partial breast irradiation and chemotherapy at different times(older method). In this study women who had their breast cancer removed but need radiation to the breast will be randomized to partial breast irradiation at the same time as chemotherapy or partial breast radiation at a different time than chemotherapy. Randomization is like flipping a coin but in this study about 2 of every 3 women will get the new method.
Key EligibilityIn order to be eligible to take part in this trial, patients must meet the following criteria:

  • Females 18 years or older
  • Invasive Adenocarcinoma of the Breast
For a full list of participation criteria, please visit
Applicable Disease SitesBreast
Participating InstitutionsIU Health Arnett
    IU Health Ball Memorial Hospital
      IU Health Central Indiana Cancer Centers
        Indiana University (IU)
          Johns Hopkins University
            Parkview Health System
              Reading Hospital
                University of Texas-San Antonio
                  WellSpan Health York Hospital
                    Treatment TypeTreatment
                    ContactPhone: (317) 278-5632